Forbes February 3, 2023
Joshua Cohen

Amazon is adding RxPass to its pharmacy footprint. Purportedly, it’s competing with Mark Cuban’s Cost Plus Drug Company (MCCPDC). But, limitations suggest it isn’t yet a real competitor.

By paying a monthly flat fee of $5 an Amazon Prime members can obtain as many generic drugs as they need, among an initial set of 50 medications indicated for conditions, such as high blood pressure, anxiety, and male pattern baldness. Amazon’s new initiative will operate within its existing pharmacy infrastructure and distribution channels.

Paying a low, flat cash rate for generics isn’t unprecedented. Walmart, among others, has such a program.

And, for two years Mark Cuban’s Cost Plus Drug Company (MCCPDC) has been making waves in the cash business for generic...

Today's Sponsors


Today's Sponsor


Topics: Pharma, Pharma / Biotech
Drugmakers counter HHS' first offers in Medicare price talks
Pfizer stops buildout of $350M Seagen plant, leaving 120 workers' roles in question
Walgreens CEO: Shields Specialty Pharmacy Key To Growth And Won’t Be Sold
ARPA-H behind on duplicative research efforts, GAO says
Retail pharmacies to begin selling OTC birth control within weeks

Share This Article